J&J's 5th incubator set for Texas Medical Center
This article was originally published in Scrip
Executive Summary
Johnson & Johnson's first incubator for biotechnology startups was established in San Diego in 2012 and two years later the company plans to open its fifth Janssen Labs – now known as J-Labs – in Houston, Texas. J-Labs@TMC will be affiliated with the Texas Medical Center (TMC) and its brand new Innovation Institute, which educates life science entrepreneurs about starting their own companies and runs an accelerator to help TMC doctors and scientists launch startups.
You may also be interested in...
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.
Sage’s Dalzanemdor Prospects In Doubt After First Mid-Stage Readout
Dalzanemdor (SAGE-718) showed no difference from placebo in a Phase II Parkinson’s disease study, raising concerns about readouts later this year in Huntington’s and Alzheimer’s diseases.
First Phase III Depression Data For Intra-Cellular’s Caplyta Exceed Expectations
With positive results from the first Phase III trial of lumateperone in major depressive disorder and a second readout expected later this quarter, the company plans a supplemental filing in late 2024.